排序方式: 共有43条查询结果,搜索用时 15 毫秒
1.
2.
3.
为解决能源和环境两大难题,使发动机工作在稀薄燃烧区,而稀薄燃烧技术的关键是发动机空燃比的控制;采用先进的计算机控制技术使发动机在最佳稀薄空燃比下工作,有效改善发动机动力性、燃油经济性、降低尾气污染。 相似文献
4.
5.
6.
采用分子标记辅助选择与常规育种技术相结合,以湖北白猪Ⅳ系为基础,培育抗应激品系.经过5个世代的选育,应激敏感基因已彻底清除;品系的各项经济性状达到并超过育种目标的要求.后备公母猪6月龄体质量分别为104.04 kg和97.83 kg,达90 kg日龄分别为164.76 d和169.42 d,活体背膘厚为1.59 cm和1.50 cm;经产母猪产仔数达12.82~12.86头;同胞测定猪达90 kg日龄166.61 d,饲料利用率2.76:1,胴体瘦肉率61.32%.以抗应激品系为母本,与高瘦肉率的皮特蓝、杜洛克公猪杂交,生产“皮×抗”、“杜×抗”杂优商品猪,达90 kg体质量日龄分别为156.59 d和160.35 d,饲料利用率分别为2.33:1和2.34:1,瘦肉率分别为64.09%和64.64%,肌内脂肪分别为2.56%和3.12%,是理想的杂优商品猪生产配套组合. 相似文献
7.
猪日瘦肉量的生化遗传标记筛选研究 总被引:3,自引:0,他引:3
采用聚丙烯酰胺凝胶电泳和分光光度计比色法分别测定了杜×长大66头杂种猪的5种同工酶多态性。(Est2,Hpx,Am1,Am2,Cp) 和6种酶活性(GPT,GOT,Akp,Acp,Amy,Cp),并对其与猪日瘦肉量的关系进行了线性模型分析、相关分析和回归分析。结果表明,5种同工酶位点均表现为多态性,但对日瘦肉量效应都不显着;6 种酶活性中,2 种酶活(Akp 和 GPT) 与日瘦肉量相关显着。 相似文献
8.
9.
选取60±1.5 kg、90.0±1.5 kg杜长大(D×L×Y)生长育肥猪48头(公母比例为1∶1),通过对平均采食量(ADFI)、平均日增重(ADG)和料重比(F/G)进行比较分析,考察蛋白和能量水平对其生长性能的影响。结果表明:日粮能量和蛋白水平对60~90 kg瘦肉型生长育肥猪ADG、ADFI和F/G均有显著影响(P<0.05);日粮能量和蛋白水平对90~120 kg生长育肥猪ADG的影响不显著(P>0.05),对ADFI、F/G影响显著(P<0.05)。60~90 kg、90~120kg阶段杜长大生长育肥猪适宜的能量和蛋白水平分别为13.90 MJ.kg-1、15.90%和14.62 MJ.kg-1、14.90%;多元回归分析得到90~120 kg瘦肉型生长育肥猪DEI、CPI与ADG的回归方程为:ΔW=-12.772DEI+23.467CPI+351.156(R2=0.881,P<0.05)。 相似文献
10.
Freeman LM 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2012,26(1):3-17
Cachexia is the loss of lean body mass (LBM) that affects a large proportion of dogs and cats with congestive heart failure (CHF), chronic kidney disease (CKD), cancer, and a variety of other chronic diseases. Sarcopenia, the loss of LBM that occurs with aging, is a related syndrome, although sarcopenia occurs in the absence of disease. As many of the diseases associated with muscle loss are more common in aging, cachexia and sarcopenia often are concurrent problems. Both cachexia and sarcopenia have important clinical implications because they are associated with increased morbidity and mortality. The pathophysiology of these 2 syndromes is complex and multifactorial, but recent studies have provided new information that has helped to clarify mechanisms and identify potential new targets for treatment. Newly identified mechanisms and pathways that mediate cachexia appear to act by increasing energy requirements, decreasing energy intake, impairing nutrient absorption, and causing metabolic alterations. Whereas cachexia and sarcopenia are important areas of research for drug development in people, they are only beginning to be recognized in veterinary medicine. Greater awareness and earlier diagnosis will help provide practical approaches to managing body weight and lean tissue in dogs and cats, as well as more directed targets for treatment. 相似文献